<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00336232</url>
  </required_header>
  <id_info>
    <org_study_id>R01DK069341</org_study_id>
    <nct_id>NCT00336232</nct_id>
  </id_info>
  <brief_title>Determinants of Vitamin K Metabolism</brief_title>
  <official_title>Dietary and Non-dietary Components of Vitamin K Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tufts University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tufts University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn how the body responds to different amounts of vitamin K
      in the diet in order to understand the roles that vitamin K may have in the body. We also
      need to determine if older adults need more or less vitamin K in their diet compared to
      younger adults in order to maintain normal body stores of vitamin K.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin K has a role in bone health, but little is known about vitamin K metabolism in aging
      and in maintenance of bone mass. The limited understanding of vitamin K metabolism impedes
      the establishment of dietary recommendations for vitamin K, and the interpretation of results
      from clinical trials on vitamin K supplementation and bone health of women in a narrow age
      group. This study is the first to assess the role of dietary and other factors that influence
      the response to vitamin K status and bone turnover to vitamin K depletion and repletion in
      adults. This study also compares the absorption efficiency and body retention of vitamin K
      relative to current vitamin K status. Men and women [21 younger (18-40y) and 21 older (55+y)]
      will participate in a 62-d metabolic study, with a 5d run-in period, followed by a 28d
      dietary vitamin K restriction period (10 ug/d), and ending with a 28d dietary vitamin K
      supplementation period (500 ug/d). Coagulation times will be monitored during the dietary
      restriction period. Serial measurements of vitamin K status markers and of bone turnover
      markers will show the response of vitamin K to dietary manipulation for both age groups under
      identically controlled dietary conditions. Deuterium-labeled vitamin K in collards will be
      used to compare the absorption of vitamin K during a vitamin K-deplete state to that of a
      vitamin K-replete state. Vitamin K is transported in triglyceride-rich lipoproteins, which
      may vary among individuals due to differences in adiposity and lipid homeostasis. Therefore,
      measurement of body composition by Dual Energy X-Ray Absorptiometry (DXA) and plasma lipids
      will provide insight into the role of lipids in absorption and transport of vitamin K. The
      findings of this study are critical for the interpretation of the epidemiologic and clinical
      data used to determine the protective role vitamin K may have in chronic disease prevention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma Phylloquinone</measure>
    <time_frame>2 months</time_frame>
    <description>Plasma phylloquinone in response to phylloquinone depletion and repletion</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Aging</condition>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>Diet Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>28 day diet low vitamin K, 28 day diet high vitamin K</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin K</intervention_name>
    <description>phylloquinone (vitamin K1) 500 mcg daily in third month</description>
    <arm_group_label>Diet Intervention</arm_group_label>
    <other_name>phylloquinone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Exclusion Criteria:

          -  kidney, GI, or liver disease requiring treatment

          -  prescribed osteoporosis medications in the previous 3 months

          -  use of acid reducers more than twice per week

          -  blood clotting disorder and/or abnormal clotting time

          -  warfarin or anticoagulant use in the previous 12 months

          -  diabetes

          -  smoking

          -  hormone therapy in the previous 3 months

          -  oral contraceptive use in the previous 3 months; pregnancy

          -  strict vegetarian diet
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah L Booth, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tufts Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging at Tufts University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.hnrc.tufts.edu</url>
    <description>Jean Mayer USDA Human Nutrition Research Center on Aging site</description>
  </link>
  <reference>
    <citation>Harrington DJ, Soper R, Edwards C, Savidge GF, Hodges SJ, Shearer MJ. Determination of the urinary aglycone metabolites of vitamin K by HPLC with redox-mode electrochemical detection. J Lipid Res. 2005 May;46(5):1053-60. Epub 2005 Feb 1.</citation>
    <PMID>15722567</PMID>
  </reference>
  <reference>
    <citation>Erkkilä AT, Lichtenstein AH, Dolnikowski GG, Grusak MA, Jalbert SM, Aquino KA, Peterson JW, Booth SL. Plasma transport of vitamin K in men using deuterium-labeled collard greens. Metabolism. 2004 Feb;53(2):215-21.</citation>
    <PMID>14767874</PMID>
  </reference>
  <reference>
    <citation>Booth SL, Martini L, Peterson JW, Saltzman E, Dallal GE, Wood RJ. Dietary phylloquinone depletion and repletion in older women. J Nutr. 2003 Aug;133(8):2565-9.</citation>
    <PMID>12888638</PMID>
  </reference>
  <reference>
    <citation>Booth SL, Lichtenstein AH, O'Brien-Morse M, McKeown NM, Wood RJ, Saltzman E, Gundberg CM. Effects of a hydrogenated form of vitamin K on bone formation and resorption. Am J Clin Nutr. 2001 Dec;74(6):783-90.</citation>
    <PMID>11722960</PMID>
  </reference>
  <results_reference>
    <citation>Traber MG, Leonard SW, Bobe G, Fu X, Saltzman E, Grusak MA, Booth SL. α-Tocopherol disappearance rates from plasma depend on lipid concentrations: studies using deuterium-labeled collard greens in younger and older adults. Am J Clin Nutr. 2015 Apr;101(4):752-9. doi: 10.3945/ajcn.114.100966. Epub 2015 Mar 4. Erratum in: Am J Clin Nutr. 2017 Feb;105(2):543.</citation>
    <PMID>25739929</PMID>
  </results_reference>
  <results_reference>
    <citation>Truong JT, Fu X, Saltzman E, Al Rajabi A, Dallal GE, Gundberg CM, Booth SL. Age group and sex do not influence responses of vitamin K biomarkers to changes in dietary vitamin K. J Nutr. 2012 May;142(5):936-41. doi: 10.3945/jn.111.154807. Epub 2012 Mar 21.</citation>
    <PMID>22437558</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2006</study_first_submitted>
  <study_first_submitted_qc>June 12, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2006</study_first_posted>
  <results_first_submitted>March 7, 2016</results_first_submitted>
  <results_first_submitted_qc>April 22, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 30, 2016</results_first_posted>
  <last_update_submitted>October 23, 2017</last_update_submitted>
  <last_update_submitted_qc>October 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tufts University</investigator_affiliation>
    <investigator_full_name>Sarah Booth</investigator_full_name>
    <investigator_title>Senior Scientist</investigator_title>
  </responsible_party>
  <keyword>Vitamin K metabolism</keyword>
  <keyword>Bone health</keyword>
  <keyword>Metabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin K</mesh_term>
    <mesh_term>Vitamin K 1</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Vitamin K Diet Intervention</title>
          <description>5 day baseline vitamin K
Vitamin K: phylloquinone (vitamin K1) 200 mcg daily
28 day diet low vitamin K
Vitamin K: phylloquinone (vitamin K1) approx. 10 mcg daily for 28 days
treatment started day 6, completed day 33
28 day diet high vitamin K
Vitamin K: phylloquinone (vitamin K1) 500 mcg daily in third month
treatment started day 34, ended day 61</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Baseline (200mcg Daily)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Low Vitamin K (10mcg Daily)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>High Vitamin K (500mcg Daily)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Diet Intervention</title>
          <description>5 day baseline vitamin K
Vitamin K: phylloquinone (vitamin K1) 200 mcg daily
28 day diet low vitamin K
Vitamin K: phylloquinone (vitamin K1) approx. 10 mcg daily for 28 days
treatment started day 6, completed day 33
28 day diet high vitamin K
Vitamin K: phylloquinone (vitamin K1) 500 mcg daily in third month
treatment started day 34, ended day 61</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="42"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Plasma phylloquinone (nmol/L)</title>
          <units>nmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.8" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Plasma Phylloquinone</title>
        <description>Plasma phylloquinone in response to phylloquinone depletion and repletion</description>
        <time_frame>2 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Diet Intervention</title>
            <description>5 day baseline vitamin K
Vitamin K: phylloquinone (vitamin K1) 200 mcg daily
28 day diet low vitamin K
Vitamin K: phylloquinone (vitamin K1) approx. 10 mcg daily for 28 days
treatment started day 6, completed day 33
28 day diet high vitamin K
Vitamin K: phylloquinone (vitamin K1) 500 mcg daily in third month
treatment started day 34, ended day 61</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Phylloquinone</title>
          <description>Plasma phylloquinone in response to phylloquinone depletion and repletion</description>
          <units>nmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>low vitamin K</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>high vitamin K</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>duration of study, up to 62 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Diet Intervention</title>
          <description>5 day baseline vitamin K
Vitamin K: phylloquinone (vitamin K1) 200 mcg daily
28 day diet low vitamin K
Vitamin K: phylloquinone (vitamin K1) approx. 10 mcg daily for 28 days
treatment started day 6, completed day 33
28 day diet high vitamin K
Vitamin K: phylloquinone (vitamin K1) 500 mcg daily in third month
treatment started day 34, ended day 61</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>High blood pressure</sub_title>
                <description>not related to intervention</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="42"/>
              </event>
              <event>
                <sub_title>History of blood clotting</sub_title>
                <description>ineligible for study enrollment</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Facial swelling</sub_title>
                <description>not related to intervention</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sarah Booth, PhD</name_or_title>
      <organization>Tufts University</organization>
      <phone>617-556-3231</phone>
      <email>sarah.booth@tufts.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

